Piper Jaffray
Piper Jaffray is a client-focused, middle market investment bank and institutional securities firm founded in 1895 and based in Minneapolis, Minnesota.
Its Investment Banking activities include raising capital through equity and debt financings for corporate clients; providing financial advisory services relating to mergers and acquisitions to consumer, financial institutions, health care, technology, alternative energy, business services, and industrial growth sectors; underwriting debt issuances for government and non-profit clients; and providing financial advisory and interest rate risk management services.
The company's equity and fixed income institutional sales and trading activities include equity and fixed income advisory and trade execution services for public and private corporations, public entities, non-profit clients, and institutional investors.
-
Piper Jaffray Upgrades Watson Pharmaceuticals (WPI) to Overweight
-
Analysts Defend Questcor (QCOR) On Free-Fall In Shares
-
Piper Jaffray Downgrades Watson Pharmaceuticals (WPI) to Neutral
-
Notable Analyst Rating Changes 01/25: (WPI) (ALU) (TEX) Upgraded; (MS) (MTG) (NVDA) Downgraded
-
Watson Pharmaceutical (WPI) volatility at 33 into FDA declining to recommend Prochieve
-
Watson Pharma (WPI) Receives Upgrades, PT Boosts from Piper and UBS
-
Piper Jaffray Specialty Pharma 2Q10 Preview: Street Estimates Sufficiently Conservative to Beatable
-
Piper Jaffray Upgrades Watson Pharmaceuticals (WPI) to Neutral Amid Better Visibility on Long-Term Growth
-
Piper Jaffray Initiates Coverage on Watson Pharmaceuticals (WPI) with an Underweight; Hard to Envision Significant Organic Growth
